Cat. No. Name Size Price Add Cart
KI0981Ketek25 mg$3200

Chemical Characteristic

Product NameKetek
SynonymsTelithromycin, HMR 3647
CAS No.191114-48-4
Molecular Weight 812
FormulaC43H65N5O10
Chemical Name(1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone
Smiles[C@@H]12[C@H](C(=O)[C@@H](C[C@]([C@@H]([C@H](C(=O)[C@H](C(=O)O[C@@H]([C@]1(OC(=O)N2CCCCn1cnc(c1)c1cnccc1)C)CC)C)C)OC1O[C@@H](C[C@@H]([C@H]1O)N(C)C)C)(C)OC)C)C
Chemical Structure

Biological activities

Ketek is a ketolide antibiotic. The MIC of ketek is 4 µg/mL.[1] The mean MIC90s of ketek are 0.12 mg/L, 0.03 mg/L and 0.001 mg/L against the common respiratory pathogens Streptococcus pneumoniae, Moraxella catarrhalis and the atypical microorganism Mycoplasma pneumoniae, respectively.[2] Ketek inhibits protein synthesis resulting in preventing bacteria from growing. Ketek binds to the subunit 50S of the bacterial ribosome. Ketek prevents the progression of the growing polypeptide chain. Ketek has over 10 times higher affinity to the subunit 50S than erythromycin. In addition, ketek strongly binds simultaneously to two domains of 23S RNA of the 50S ribosomal subunit, where older macrolides bind strongly only to one domain and weakly to the second domain. Ketek can also prevent the production of ribosomal subunits 50S and 30S. Ketek prevents the ribosomal exit tunnel and interacts with domains II and V of the 23S RNA.[3] Ketek is metabolized mainly in the liver. Ketek is mainly metabolized via CYP3A1/2 in rats.[4]

Protocols

Ketek is dissolved in distilled water with a few drops of acetic acid.[4]

References

[1] Canu A, et al. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2002, 46(1): 125-131.
[2] Khair OA, et al. Lung concentrations of telithromycin after oral dosing. J Antimicrob Chemother. 2001, 47(6): 837-840.
[3] Berisio R, et al. Structural insight into the antibiotic action of telithromycin against resistant mutants. J Bacteriol. 2003, 185(14): 4276-4279.
[4] Lee JH, et al. Effects of acute renal failure on the pharmacokinetics of telithromycin in rats: negligible effects of increase in CYP3A1 on the metabolism of telithromycin. Biopharm Drug Dispos. 2007, 28(4): 157-166.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.